3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Recurrence
1
Ovarian Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Sorafenib
20
Bevacizumab
7
pembrolizumab
5
Oxaliplatin
5
Melphalan
5
Leucovorin
5
Irinotecan
5
Nivolumab
4
Ipilimumab
4
Fluorouracil
4
Cyclophosphamide
4
Capecitabine
4
fludarabine
3
Sirolimus
3
Radiosurgery
3
Gemcitabine
3
Filgrastim
3
Carboplatin
3
toripalimab
2
spartalizumab
2
regorafenib
2
pazopanib
2
lenvatinib
2
ixabepilone
2
durvalumab
2
atezolizumab
2
Vorinostat
2
Thiotepa
2
Temozolomide
2
Sirtuins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Liver Neoplasms
×
perflutren
×
Clear all
NCT00955097
2013-10-21
Definity®
University of Louisville
Phase 1
Terminated
6 enrolled